Stay updated on Pembrolizumab Plus Lenvatinib Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.

Latest updates to the Pembrolizumab Plus Lenvatinib Clinical Trial page
- Check3 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates access to the study details is blocked, with the usual navigation and study information not shown.SummaryDifference20%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page footer now shows Revision: v3.6.6, replacing the previous v3.6.5. This reflects a small version update to the page.SummaryDifference0.0%

- Check31 days agoChange DetectedA new line '2018 ( U.S. NIH Grant/Contract )' was added to the list of Other Study ID Numbers, signifying NIH funding/identifier associated with the LEAP-005 study.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a small patch to the page's tooling. No substantive study content or user-facing information appears to have changed.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page footer’s Revision tag was updated from v3.6.3 to v3.6.4, indicating a small underlying update to the page or its template. This change does not alter the study details or displayed information.SummaryDifference0.0%

- Check81 days agoChange DetectedA final publication citation for LEAP-005 colorectal cancer results was added to the Publications section (Clin Colorectal Cancer. 2026 Jun;25(2):225-238.e2). The previous online-ahead-of-print citation (Clin Colorectal Cancer. 2026 Jan 22:S1533-0028(26)00005-8) was removed/replaced with the finalized record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Lenvatinib Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Lenvatinib Clinical Trial page.